Buenavista Equity Partners has secured a 71.2% stake in Madrid‑based Tiryaq Medical Group, a trauma care specialist, through its Buenavista Buyout Innvierte III España and BV Healthcare Growth Innvierte I funds. The deal combines existing share purchases with a capital injection to fuel expansion across Spain. Founded by orthopedic surgeon Ghassan Elgeadi Saleh, Tiryaq runs two clinics in Madrid and trauma units in over 10 hospitals across Madrid, Barcelona and Málaga, handling more than 230,000 patient contacts in 2025, generating €13 million in revenue and performing over 5,000 surgeries annually. Elgeadi will stay on as leader, while Buenavista will add capital and operational expertise to broaden the care network, introduce new specialists and services, and pursue complementary acquisitions in a fragmented market. Jorge Juliani Aznar, partner at Buenavista Equity Partners, highlighted the firm’s healthcare experience and its prior acquisition of fertility firm Eugin, which now operates 45 clinics with combined revenue exceeding €145 million. Buenavista manages €1.3 billion across private equity, infrastructure and venture capital. Advisors included Forvis Mazars, Baker Mc Kenzie, EY and AON for Buenavista, and You are Capital, Montero Aramburu & GVA and Grupo Aliaga for Tiryaq.
Key figures: €13 million annual revenue, >5,000 surgeries per year, >230,000 patient contacts in 2025, 71.2% stake acquisition.
The transaction marks Tiryaq’s third investment for Buenavista Buyout Innvierte III España, which follows a buy‑and‑build strategy in Spanish companies, and underscores Buenavista’s focus on growth‑stage healthcare firms.
People: Ghassan Elgeadi Saleh, Jorge Juliani Aznar.
Locations: Madrid, Barcelona, Málaga.
Companies: Buenavista Equity Partners, Tiryaq Medical Group, Eugin, Instituto Bernabeu, Forvis Mazars, Baker Mc Kenzie, EY, AON, You are Capital, Montero Aramburu & GVA, Grupo Aliaga.
Source: PE Hub · Summarized by HeadlinesBriefing